Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Dunkel

Showing results (151-160 of 237) with videos related to

Pageof 24
Sort By:
Pediatric Blood & Cancer|May 21, 2010
Intensive multimodality therapy for patients with stage 4a metastatic retinoblastomaIra J Dunkel, Yasmin Khakoo, Nancy A Kernan, et al.
Pediatric Blood & Cancer|September 30, 2006
Brainstem primitive neuroectodermal tumors (bstPNET): results of treatment with intensive induction chemotherapy followed by consolidative chemotherapy with autologous hematopoietic cell rescueJason R Fangusaro, Rima F Jubran, Jeffrey Allen, et al.
Journal of Neuro-Oncology|March 8, 2018
Patterns of relapse for children with localized intracranial ependymomaBrian De, Yasmin Khakoo, Mark M Souweidane, et al.
International Journal of Radiation Oncology, Biology, Physics|April 13, 2011
Disease control and ototoxicity using intensity-modulated radiation therapy tumor-bed boost for medulloblastomaWilliam R Polkinghorn, Ira J Dunkel, Mark M Souweidane, et al.
Pediatric Blood & Cancer|March 19, 2020
Pineoblastoma in children less than six years of age: The Head Start I, II, and III experienceMohamed S Abdelbaki, Mohammad H Abu-Arja, Tom B Davidson, et al.
Pediatric Blood & Cancer|October 10, 2006
Risk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastomaGuillermo L Chantada, Ira J Dunkel, Celia B G Antoneli, et al.
Pediatric Blood & Cancer|January 10, 2014
Whole-body magnetic resonance imaging (WB-MRI) as surveillance for subsequent malignancies in survivors of hereditary retinoblastoma: a pilot studyDanielle Novetsky Friedman, Eric Lis, Charles A Sklar, et al.
European Journal of Cancer (Oxford, England : 1990)|November 4, 2017
Phase II study of ipilimumab in adolescents with unresectable stage III or IV malignant melanomaBirgit Geoerger, Christophe Bergeron, Lia Gore, et al.
Ophthalmology Science|October 17, 2022
<i>RB1</i> Circulating Tumor DNA in the Blood of Patients with Unilateral Retinoblastoma: Before and after Intra-arterial ChemotherapyJasmine H Francis, Y Pierre Gobin, A Rose Brannon, et al.
Journal of Pediatric Surgery|March 31, 2015
Early-stage non-Spitzoid cutaneous melanoma in patients younger than 22 years of age at diagnosis: long-term follow-up and survival analysisEric J Stanelle, Klaus J Busam, Barrie S Rich, et al.
Pageof 24

Showing results (151-160 of 237) with videos related to

Sort By:
Pageof 24
Pediatric Blood & Cancer|May 21, 2010
Intensive multimodality therapy for patients with stage 4a metastatic retinoblastomaIra J Dunkel, Yasmin Khakoo, Nancy A Kernan, et al.
Pediatric Blood & Cancer|September 30, 2006
Brainstem primitive neuroectodermal tumors (bstPNET): results of treatment with intensive induction chemotherapy followed by consolidative chemotherapy with autologous hematopoietic cell rescueJason R Fangusaro, Rima F Jubran, Jeffrey Allen, et al.
Journal of Neuro-Oncology|March 8, 2018
Patterns of relapse for children with localized intracranial ependymomaBrian De, Yasmin Khakoo, Mark M Souweidane, et al.
International Journal of Radiation Oncology, Biology, Physics|April 13, 2011
Disease control and ototoxicity using intensity-modulated radiation therapy tumor-bed boost for medulloblastomaWilliam R Polkinghorn, Ira J Dunkel, Mark M Souweidane, et al.
Pediatric Blood & Cancer|March 19, 2020
Pineoblastoma in children less than six years of age: The Head Start I, II, and III experienceMohamed S Abdelbaki, Mohammad H Abu-Arja, Tom B Davidson, et al.
Pediatric Blood & Cancer|October 10, 2006
Risk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastomaGuillermo L Chantada, Ira J Dunkel, Celia B G Antoneli, et al.
Pediatric Blood & Cancer|January 10, 2014
Whole-body magnetic resonance imaging (WB-MRI) as surveillance for subsequent malignancies in survivors of hereditary retinoblastoma: a pilot studyDanielle Novetsky Friedman, Eric Lis, Charles A Sklar, et al.
European Journal of Cancer (Oxford, England : 1990)|November 4, 2017
Phase II study of ipilimumab in adolescents with unresectable stage III or IV malignant melanomaBirgit Geoerger, Christophe Bergeron, Lia Gore, et al.
Ophthalmology Science|October 17, 2022
<i>RB1</i> Circulating Tumor DNA in the Blood of Patients with Unilateral Retinoblastoma: Before and after Intra-arterial ChemotherapyJasmine H Francis, Y Pierre Gobin, A Rose Brannon, et al.
Journal of Pediatric Surgery|March 31, 2015
Early-stage non-Spitzoid cutaneous melanoma in patients younger than 22 years of age at diagnosis: long-term follow-up and survival analysisEric J Stanelle, Klaus J Busam, Barrie S Rich, et al.
Pageof 24